Dr. Gregg Stone is a world-renowned interventional cardiologist and academic leader at the forefront of cardiovascular medicine. He currently serves as Director of Academic Affairs for Mount Sinai Heart and holds dual professorships in Medicine and Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai. Previously, Dr. Stone was director of cardiovascular research and education at New York-Presbyterian/Columbia University Irving Medical Center's Center for Interventional Vascular Therapy, where he established himself as a leading figure in the field. His career trajectory has been marked by consistent leadership in advancing the science and practice of interventional cardiology across major academic medical centers in New York City.
Dr. Stone's groundbreaking research has fundamentally transformed the treatment of coronary artery disease through innovative stent technologies and interventional approaches. His landmark 2004 New England Journal of Medicine paper on polymer-based paclitaxel-eluting stents became one of the most cited works in cardiology with over 3,700 citations, establishing a new standard of care for patients with coronary artery disease. As principal investigator for approximately 130 national and international multicenter randomized trials, he has pioneered numerous advances in acute coronary syndromes, myocardial infarction therapies, and drug-eluting stent technologies that have directly improved patient outcomes worldwide. His extensive scholarly output, comprising more than 2,500 peer-reviewed publications, book chapters, and abstracts, has cemented his position as one of the most influential researchers in cardiovascular medicine.
Beyond his research achievements, Dr. Stone has been instrumental in shaping cardiovascular clinical practice guidelines and advancing the field through his leadership in major professional societies and research consortia. He continues to drive innovation in underserved areas of cardiovascular care, recently securing significant funding to study optimal coronary revascularization procedures for women and underserved minority groups, addressing critical health disparities in cardiac interventions. As a dedicated mentor, he has trained generations of interventional cardiologists who now lead programs across the United States and internationally, extending his academic influence throughout the global cardiovascular community. Dr. Stone remains actively engaged in cutting-edge research, with current focus areas including advanced coronary imaging techniques, novel antithrombotic therapies, and personalized approaches to complex coronary interventions that promise to further advance patient care in the coming decade.
